Henderson, J.; Dayalan Naidu, S.; Dinkova-Kostova, A.T.; Przyborski, S.; Stratton, R.; O′Reilly, S.
The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis. Cells 2021, 10, 2053.
https://doi.org/10.3390/cells10082053
AMA Style
Henderson J, Dayalan Naidu S, Dinkova-Kostova AT, Przyborski S, Stratton R, O′Reilly S.
The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis. Cells. 2021; 10(8):2053.
https://doi.org/10.3390/cells10082053
Chicago/Turabian Style
Henderson, John, Sharadha Dayalan Naidu, Albena T. Dinkova-Kostova, Stefan Przyborski, Richard Stratton, and Steven O′Reilly.
2021. "The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis" Cells 10, no. 8: 2053.
https://doi.org/10.3390/cells10082053
APA Style
Henderson, J., Dayalan Naidu, S., Dinkova-Kostova, A. T., Przyborski, S., Stratton, R., & O′Reilly, S.
(2021). The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis. Cells, 10(8), 2053.
https://doi.org/10.3390/cells10082053